Biotechnology stocks are not out of the woods as far as the medium-term goes, but near-term some promising bases have been formed, lows continue go get bought. It may not be a time to go all out in on the long side, but blindly shorting this ain’t high probability trading either.

Serge Berger
TheSteadyTrader.com

GET OUR FREE DAILY TRADING VIDEOS

Delivered to your inbox!

You should get your first video tomorrow!

Pin It on Pinterest

Share This